Cetera Advisors LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cetera Advisors LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,378,064
+4.1%
13,529
+3.1%
0.02%
+4.8%
Q2 2023$1,323,771
+9.9%
13,118
+0.2%
0.02%
+5.0%
Q1 2023$1,204,096
+13.0%
13,088
+11.5%
0.02%
+5.3%
Q4 2022$1,065,269
+56.0%
11,742
+30.6%
0.02%
+5.6%
Q3 2022$683,000
-11.0%
8,988
-1.0%
0.02%
+5.9%
Q2 2022$767,000
+18.4%
9,075
+22.9%
0.02%
+30.8%
Q1 2022$648,000
+6.9%
7,383
+6.5%
0.01%
+8.3%
Q4 2021$606,000
-10.8%
6,931
-16.6%
0.01%
-7.7%
Q3 2021$679,000
-6.7%
8,309
+4.1%
0.01%
-23.5%
Q2 2021$728,000
+6.0%
7,982
-0.6%
0.02%
-10.5%
Q1 2021$687,000
+10.6%
8,033
+22.1%
0.02%
-5.0%
Q4 2020$621,000
-0.6%
6,577
-8.4%
0.02%
-16.7%
Q3 2020$625,000
-8.9%
7,182
-8.6%
0.02%
-17.2%
Q2 2020$686,000
+41.7%
7,855
+33.7%
0.03%
+11.5%
Q1 2020$484,000
-14.8%
5,875
-2.7%
0.03%
+8.3%
Q4 2019$568,000
-20.4%
6,040
-26.6%
0.02%
-25.0%
Q3 2019$714,000
+1.0%
8,231
+5.7%
0.03%
+3.2%
Q2 2019$707,000
-7.5%
7,787
-2.2%
0.03%
-18.4%
Q1 2019$764,000
+50.7%
7,966
+35.4%
0.04%
+26.7%
Q4 2018$507,000
-28.8%
5,882
-28.7%
0.03%
-14.3%
Q3 2018$712,000
+176.0%
8,246
+139.2%
0.04%
+133.3%
Q2 2018$258,000
-35.7%
3,447
-30.8%
0.02%
-37.5%
Q1 2018$401,000
-4.8%
4,983
-0.3%
0.02%
-7.7%
Q4 2017$421,000
-21.2%
4,997
-19.4%
0.03%
-18.8%
Q3 2017$534,000
+19.2%
6,197
+16.0%
0.03%
+14.3%
Q2 2017$448,000
+36.6%
5,341
+20.9%
0.03%
+27.3%
Q1 2017$328,000
-8.4%
4,417
-9.5%
0.02%
-18.5%
Q4 2016$358,000
-5.8%
4,881
+1.2%
0.03%
-6.9%
Q3 2016$380,000
-33.9%
4,822
-31.0%
0.03%
-35.6%
Q2 2016$575,000
+47.1%
6,988
+29.3%
0.04%
+36.4%
Q1 2016$391,000
-29.0%
5,404
-15.7%
0.03%
-29.8%
Q4 2015$551,000
-13.1%
6,408
-7.3%
0.05%
-21.7%
Q3 2015$634,000
-44.1%
6,910
-39.6%
0.06%
-38.1%
Q2 2015$1,134,000
+0.4%
11,440
+0.4%
0.10%
-6.7%
Q1 2015$1,129,000
+6.3%
11,399
+0.1%
0.10%
+1.0%
Q4 2014$1,062,000
+21.1%
11,385
+21.9%
0.10%
+53.7%
Q3 2014$877,000
+3.4%
9,340
-0.4%
0.07%
-29.5%
Q2 2014$848,000
+12.3%
9,374
+6.2%
0.10%
-8.7%
Q1 2014$755,000
+6.8%
8,824
-0.0%
0.10%
-1.0%
Q4 2013$707,000
+3.1%
8,826
-1.1%
0.10%
-13.9%
Q3 2013$686,000
+40.3%
8,926
+28.0%
0.12%
+19.6%
Q2 2013$489,0006,9710.10%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders